
|Articles|January 6, 2003
Industry insiders continue to spar over Waxman-Hatch Act
Debate between brand and generic drug companies contues to rage over whether the Waxman-Hatch Act should be overhauled.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Interventions Help Prevent OTC Drug Abuse, Misuse, and Dependence
2
GoodRx Offers Wegovy Weight-Loss Pill at Under $150 a Month
3
How PBMs, Pharmacists Can Team Up to Improve Women's Health
4
Survey Shows Significant Gaps in Understanding of Shared Decision-Making
5










































































































































































































